US5744347A
(en)
*
|
1987-01-16 |
1998-04-28 |
Ohio University Edison Biotechnology Institute |
Yolk sac stem cells and their uses
|
US5399493A
(en)
*
|
1989-06-15 |
1995-03-21 |
The Regents Of The University Of Michigan |
Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
|
US5635386A
(en)
|
1989-06-15 |
1997-06-03 |
The Regents Of The University Of Michigan |
Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
|
US5763266A
(en)
*
|
1989-06-15 |
1998-06-09 |
The Regents Of The University Of Michigan |
Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
|
US5605822A
(en)
*
|
1989-06-15 |
1997-02-25 |
The Regents Of The University Of Michigan |
Methods, compositions and devices for growing human hematopoietic cells
|
US5061620A
(en)
*
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
US5635387A
(en)
*
|
1990-04-23 |
1997-06-03 |
Cellpro, Inc. |
Methods and device for culturing human hematopoietic cells and their precursors
|
US5840580A
(en)
*
|
1990-05-01 |
1998-11-24 |
Becton Dickinson And Company |
Phenotypic characterization of the hematopoietic stem cell
|
US5622853A
(en)
*
|
1990-05-01 |
1997-04-22 |
Becton Dickinson And Company |
T lymphocyte precursor
|
US6631842B1
(en)
*
|
2000-06-07 |
2003-10-14 |
Metrologic Instruments, Inc. |
Method of and system for producing images of objects using planar laser illumination beams and image detection arrays
|
US5541072A
(en)
*
|
1994-04-18 |
1996-07-30 |
Immunivest Corporation |
Method for magnetic separation featuring magnetic particles in a multi-phase system
|
US6010696A
(en)
*
|
1990-11-16 |
2000-01-04 |
Osiris Therapeutics, Inc. |
Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
|
US5340719A
(en)
*
|
1990-11-23 |
1994-08-23 |
Corporation Coulter |
Method and apparatus for optically screening microscopic cells
|
US5348859A
(en)
*
|
1990-11-23 |
1994-09-20 |
Coulter Corporation |
Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential
|
US5464753A
(en)
*
|
1991-03-08 |
1995-11-07 |
Univ Illinois |
Purification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expression
|
US5994088A
(en)
*
|
1991-03-08 |
1999-11-30 |
Board Of Trustees Of The University Of Illinois |
Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
|
US5849686A
(en)
*
|
1991-03-11 |
1998-12-15 |
Creative Biomolecules, Inc. |
Morphogen-induced liver regeneration
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
US5367057A
(en)
|
1991-04-02 |
1994-11-22 |
The Trustees Of Princeton University |
Tyrosine kinase receptor flk-2 and fragments thereof
|
US5185438A
(en)
*
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
WO1992017505A1
(en)
*
|
1991-04-05 |
1992-10-15 |
Board Of Regents Of The University Of Washington |
Monoclonal antibodies to stem cell factor receptors
|
US5744361A
(en)
*
|
1991-04-09 |
1998-04-28 |
Indiana University |
Expansion of human hematopoietic progenitor cells in a liquid medium
|
EP0584184A4
(en)
|
1991-04-09 |
1995-12-27 |
Indiana University Foundation |
System and process for supporting hematopoietic cells
|
EP0597964A4
(en)
*
|
1991-08-07 |
1994-11-30 |
Einstein Coll Med |
Proliferation of hepatocyte precursors.
|
US6069005A
(en)
|
1991-08-07 |
2000-05-30 |
Albert Einstein College Of Medicine Of Yeshwa University |
Hapatoblasts and method of isolating same
|
NL9101680A
(en)
*
|
1991-10-04 |
1993-05-03 |
Tno |
METHOD FOR GENETICALLY MODIFYING PRIMATE BONE MARROW CELLS AND USE CELLS PRODUCING RECOMBINANT RETROVIRAL VECTORS.
|
EP0609379A1
(en)
*
|
1991-10-23 |
1994-08-10 |
Cellpro Incorporated |
Method for freezing engrafting cells
|
DK0614485T3
(en)
*
|
1991-10-23 |
2002-10-28 |
Nexell Therapeutics Inc |
Method for selectively propagating CD34 positive cells
|
US6353150B1
(en)
*
|
1991-11-22 |
2002-03-05 |
Hsc Research And Development Limited Partnership |
Chimeric mammals with human hematopoietic cells
|
WO1993018136A1
(en)
*
|
1992-03-05 |
1993-09-16 |
Cytomed, Inc. |
Process for supporting hematopoietic progenitor cells
|
US5888499A
(en)
*
|
1992-03-23 |
1999-03-30 |
Nexell Therapeutics Inc. |
Method for increasing neutrophil populations using in vitro-derived human neutrophil precursor cells
|
AU658065B2
(en)
*
|
1992-03-23 |
1995-03-30 |
Nexell Therapeutics Inc. |
(In vitro)-derived human neutrophil precursor cells
|
US5436151A
(en)
*
|
1992-04-03 |
1995-07-25 |
Regents Of The University Of Minnesota |
Method for culturing human hematopoietic stem cells in vitro
|
US5460964A
(en)
*
|
1992-04-03 |
1995-10-24 |
Regents Of The University Of Minnesota |
Method for culturing hematopoietic cells
|
IL106295A
(en)
*
|
1992-07-10 |
2001-03-19 |
Univ Pittsburgh |
Hematopoietic facilitaroy cells
|
EP0652943B1
(en)
*
|
1992-07-10 |
2008-07-02 |
University Of Pittsburgh |
Hematopoietic facilitatory cells and their uses
|
US5849553A
(en)
*
|
1992-07-27 |
1998-12-15 |
California Institute Of Technology |
Mammalian multipotent neural stem cells
|
EP0658194A1
(en)
*
|
1992-07-27 |
1995-06-21 |
California Institute Of Technology |
Mammalian multipotent neural stem cells
|
US5589376A
(en)
*
|
1992-07-27 |
1996-12-31 |
California Institute Of Technology |
Mammalian neural crest stem cells
|
US5654183A
(en)
*
|
1992-07-27 |
1997-08-05 |
California Institute Of Technology |
Genetically engineered mammalian neural crest stem cells
|
US5693482A
(en)
*
|
1992-07-27 |
1997-12-02 |
California Institute Of Technology |
Neural chest stem cell assay
|
EP0652703A4
(en)
*
|
1992-07-28 |
1996-05-29 |
Steven Kessler |
Methods for positive immunoselection of stem cells.
|
CA2080255A1
(en)
*
|
1992-07-31 |
1994-02-01 |
Connie J. Eaves |
Primitive hematopoietic stem cell preparations
|
DE69332024T2
(en)
*
|
1992-09-03 |
2002-11-28 |
Systemix Inc |
THE SEPARATION OF LIVING MAMMAL CELLS BY HIGH-SPEED FLOW CYTOMETRY
|
US5466572A
(en)
*
|
1992-09-03 |
1995-11-14 |
Systemix, Inc. |
High speed flow cytometric separation of viable cells
|
US5342776A
(en)
*
|
1992-09-04 |
1994-08-30 |
Bolnet Marie C N |
Avian hemopoietic progenitor cells
|
WO1994008039A1
(en)
*
|
1992-10-02 |
1994-04-14 |
Systemix, Inc. |
Method of enrichment for human hematopoietic stem cells using c-kit
|
US5766951A
(en)
*
|
1992-11-12 |
1998-06-16 |
Quality Biological, Inc. |
Serum-free medium supporting growth and proliferation of normal bone marrow cells
|
EP0670735B1
(en)
|
1992-11-13 |
1997-04-02 |
Board Of Regents Of The University Of Washington |
Peripheralization of hematopoietic stem cells
|
SG86980A1
(en)
*
|
1992-11-16 |
2002-03-19 |
Applied Immunesciences |
Pluripotential quiescent stem cell population
|
US5409710A
(en)
*
|
1993-04-20 |
1995-04-25 |
Endocon, Inc. |
Foam cell drug delivery
|
AU678469B2
(en)
*
|
1993-05-03 |
1997-05-29 |
Genentech Inc. |
Inhibition of leukocyte adhesion
|
AU693452B2
(en)
*
|
1993-05-24 |
1998-07-02 |
Ximerex, Inc |
Surrogate tolerogenesis for the development of tolerance to xenografts
|
US5554512A
(en)
*
|
1993-05-24 |
1996-09-10 |
Immunex Corporation |
Ligands for flt3 receptors
|
NZ314644A
(en)
|
1993-05-24 |
2000-11-24 |
Immunex Corp |
Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
|
US5772994A
(en)
*
|
1993-05-28 |
1998-06-30 |
The University Of Pittsburgh |
Hematopoietic facilitatory cells and their uses
|
US6033906A
(en)
*
|
1993-07-26 |
2000-03-07 |
California Institute Of Technology |
Methods for differentiating neural stem cells to glial cells using neuregulins
|
JPH09502167A
(en)
*
|
1993-07-29 |
1997-03-04 |
システミックス,インコーポレイテッド |
Novel stem cell marker
|
AU685506B2
(en)
*
|
1993-08-25 |
1998-01-22 |
Systemix, Inc. |
Method for producing a highly enriched population of hematopoietic stem cells
|
EP1734053A3
(en)
*
|
1993-09-08 |
2009-04-22 |
Imclone Systems, Inc. |
Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
|
AU7798294A
(en)
*
|
1993-09-17 |
1995-04-03 |
Systemix, Inc. |
Method for obtaining a cell population enriched in stem cells and compositions derived therefrom
|
US5409813A
(en)
*
|
1993-09-30 |
1995-04-25 |
Systemix, Inc. |
Method for mammalian cell separation from a mixture of cell populations
|
US5599703A
(en)
*
|
1993-10-28 |
1997-02-04 |
The United States Of America As Represented By The Secretary Of The Navy |
In vitro amplification/expansion of CD34+ stem and progenitor cells
|
US6190655B1
(en)
|
1993-12-03 |
2001-02-20 |
Immunex Corporation |
Methods of using Flt-3 ligand for exogenous gene transfer
|
JPH09508007A
(en)
*
|
1994-01-05 |
1997-08-19 |
ユニバーシティー オブ ピッツバーグ |
Monoclonal antibody against antigen expressed by hematopoietic promoting cells
|
US6001654A
(en)
*
|
1994-01-28 |
1999-12-14 |
California Institute Of Technology |
Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
|
US20030108545A1
(en)
*
|
1994-02-10 |
2003-06-12 |
Patricia Rockwell |
Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
|
US6448077B1
(en)
*
|
1994-02-10 |
2002-09-10 |
Imclone Systems, Inc. |
Chimeric and humanized monoclonal antibodies specific to VEGF receptors
|
US7294331B2
(en)
*
|
1994-03-07 |
2007-11-13 |
Immunex Corporation |
Methods of using flt3-ligand in hematopoietic cell transplantation
|
US6242417B1
(en)
|
1994-03-08 |
2001-06-05 |
Somatogen, Inc. |
Stabilized compositions containing hemoglobin
|
US5631219A
(en)
*
|
1994-03-08 |
1997-05-20 |
Somatogen, Inc. |
Method of stimulating hematopoiesis with hemoglobin
|
US5972627A
(en)
*
|
1994-06-15 |
1999-10-26 |
Systemix, Inc. |
Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells obtained thereby
|
US5985660A
(en)
*
|
1994-06-15 |
1999-11-16 |
Systemix, Inc. |
Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
|
ATE242335T1
(en)
*
|
1994-06-15 |
2003-06-15 |
Systemix Inc |
POPULATION OF CELLS ENRICHED WITH MYELOID AND/OR LYMPHOID PRECURSORS AND METHOD FOR OBTAINING AND USING THEM
|
US5972703A
(en)
*
|
1994-08-12 |
1999-10-26 |
The Regents Of The University Of Michigan |
Bone precursor cells: compositions and methods
|
US5474687A
(en)
*
|
1994-08-31 |
1995-12-12 |
Activated Cell Therapy, Inc. |
Methods for enriching CD34+ human hematopoietic progenitor cells
|
US5827742A
(en)
*
|
1994-09-01 |
1998-10-27 |
Beth Israel Deaconess Medical Center, Inc. |
Method of selecting pluripotent hematopioetic progenitor cells
|
US5650317A
(en)
*
|
1994-09-16 |
1997-07-22 |
Michigan State University |
Human breast epithelial cell type with stem cell and luminal epithelial cell characteristics
|
US6140119A
(en)
*
|
1994-09-16 |
2000-10-31 |
Michigan State University |
Expression of estrogen receptors in type I and type II human breast epithelial cells
|
US5686577A
(en)
*
|
1994-10-17 |
1997-11-11 |
Cornell Research Foundation, Inc. |
T cell factors influencing B cell development
|
AU4254396A
(en)
*
|
1994-11-14 |
1996-06-06 |
Novartis Ag |
Methods of inducing cell death of primitive hematopoietic cells and compositions for induction thereof
|
US5665557A
(en)
*
|
1994-11-14 |
1997-09-09 |
Systemix, Inc. |
Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
|
US5677136A
(en)
*
|
1994-11-14 |
1997-10-14 |
Systemix, Inc. |
Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
|
US5610056A
(en)
*
|
1994-11-16 |
1997-03-11 |
Amgen Inc. |
Use of stem cell factor interleukin-6 and soluble interleukin-6 receptor to induce the development of hematopoietic stem cells
|
US5874301A
(en)
*
|
1994-11-21 |
1999-02-23 |
National Jewish Center For Immunology And Respiratory Medicine |
Embryonic cell populations and methods to isolate such populations
|
US5665350A
(en)
*
|
1994-11-23 |
1997-09-09 |
University Of Massachusetts Medical Center |
Cell cycle dependent transplantation and ex vivo gene therapy
|
JPH11506902A
(en)
*
|
1994-12-01 |
1999-06-22 |
ベス イズレイル ディーコネス メディカル センター インコーポレイテッド |
In vitro T lymphocyte generation system
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
GB9502022D0
(en)
*
|
1995-02-02 |
1995-03-22 |
Abuljadayel Ilham M S |
A method for preparing lymphohaematopoietic progenitor cells
|
US9068164B1
(en)
*
|
1995-02-02 |
2015-06-30 |
Tristem Trading (Cyprus) Limited |
Method of preparing an undifferentiated cell
|
US5830755A
(en)
*
|
1995-03-27 |
1998-11-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
T-cell receptors and their use in therapeutic and diagnostic methods
|
US5876956A
(en)
*
|
1995-05-15 |
1999-03-02 |
Johns Hopkins University School Of Medicine |
Methods for identification or purification of cells containing an enzymatic intracellular marker
|
US5674750A
(en)
*
|
1995-05-19 |
1997-10-07 |
T. Breeders |
Continuous selective clonogenic expansion of relatively undifferentiated cells
|
US5925567A
(en)
*
|
1995-05-19 |
1999-07-20 |
T. Breeders, Inc. |
Selective expansion of target cell populations
|
US6015554A
(en)
*
|
1995-06-07 |
2000-01-18 |
Systemix, Inc. |
Method of reconstituting human lymphoid and dendritic cells
|
US5861313A
(en)
*
|
1995-06-07 |
1999-01-19 |
Ontogeny, Inc. |
Method of isolating bile duct progenitor cells
|
US5728581A
(en)
*
|
1995-06-07 |
1998-03-17 |
Systemix, Inc. |
Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
|
WO1996040875A1
(en)
*
|
1995-06-07 |
1996-12-19 |
Novartis Ag |
Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein
|
US20020182730A1
(en)
*
|
1995-07-26 |
2002-12-05 |
Micheal L. Gruenberg |
Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
|
US7361330B2
(en)
*
|
1995-10-04 |
2008-04-22 |
Immunex Corporation |
Methods of using flt3-ligand in the treatment of fibrosarcoma
|
US20020034517A1
(en)
*
|
1995-10-04 |
2002-03-21 |
Kenneth Brasel |
Dendritic cell stimulatory factor
|
US7150992B1
(en)
|
1995-10-04 |
2006-12-19 |
Innunex Corporation |
Methods of preparing dendritic cells with flt3-ligand and antigen
|
US6060052A
(en)
*
|
1995-10-30 |
2000-05-09 |
Systemix, Inc. |
Methods for use of Mpl ligands with primitive human hematopoietic stem cells
|
US5910434A
(en)
|
1995-12-15 |
1999-06-08 |
Systemix, Inc. |
Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
|
WO1997022708A1
(en)
*
|
1995-12-19 |
1997-06-26 |
Systemix, Inc. |
Primate cluster-forming embryonic hematopoietic stem cells
|
WO1997026326A1
(en)
*
|
1996-01-16 |
1997-07-24 |
Depuy Orthopaedics, Inc. |
Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
|
WO1997033978A1
(en)
*
|
1996-03-12 |
1997-09-18 |
Life Technologies, Inc. |
Hematopoietic cell culture nutrient supplement
|
US6455678B1
(en)
*
|
1996-04-26 |
2002-09-24 |
Amcell Corporation |
Human hematopoietic stem and progenitor cell antigen
|
US5843633A
(en)
*
|
1996-04-26 |
1998-12-01 |
Amcell Corporation |
Characterization of a human hematopoietic progenitor cell antigen
|
US5928638A
(en)
*
|
1996-06-17 |
1999-07-27 |
Systemix, Inc. |
Methods for gene transfer
|
EP0937461B1
(en)
*
|
1996-07-10 |
2005-07-06 |
Meiji Dairies Corporation |
Use of proteins from the mk family as hematopoietic factor
|
IL128348A
(en)
*
|
1996-08-19 |
2008-08-07 |
Univ Massachusetts |
Method of producing embryonic or stem like cell lines by transplantation of cell nuclei from animal or mammal, such cells and uses thereof
|
US7696404B2
(en)
*
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
US5945337A
(en)
|
1996-10-18 |
1999-08-31 |
Quality Biological, Inc. |
Method for culturing CD34+ cells in a serum-free medium
|
US6043348A
(en)
*
|
1996-11-13 |
2000-03-28 |
Lawman; Michael J. P. |
Antibody recognizing a small subset of human hematopoietic cells
|
CA2274469C
(en)
*
|
1996-12-10 |
2009-09-01 |
Tony Peled |
Serum-derived factor inducing cell differentiation and medical uses thereof
|
EP1007735A1
(en)
*
|
1997-02-24 |
2000-06-14 |
TM Technologies Inc. |
Anti-sense oligonucleotide pharmacological agents
|
US6090622A
(en)
*
|
1997-03-31 |
2000-07-18 |
The Johns Hopkins School Of Medicine |
Human embryonic pluripotent germ cells
|
US6331406B1
(en)
|
1997-03-31 |
2001-12-18 |
The John Hopkins University School Of Medicine |
Human enbryonic germ cell and methods of use
|
US5948426A
(en)
*
|
1997-05-03 |
1999-09-07 |
Jefferies; Steven R. |
Method and article to induce hematopoietic expansion
|
AU9472998A
(en)
*
|
1997-09-04 |
1999-03-22 |
Science Research Laboratory, Inc. |
Cell separation using electric fields
|
US6440734B1
(en)
*
|
1998-09-25 |
2002-08-27 |
Cytomatrix, Llc |
Methods and devices for the long-term culture of hematopoietic progenitor cells
|
US6093531A
(en)
*
|
1997-09-29 |
2000-07-25 |
Neurospheres Holdings Ltd. |
Generation of hematopoietic cells from multipotent neural stem cells
|
US5955257A
(en)
*
|
1997-10-21 |
1999-09-21 |
Regents Of The University Of Minnesota |
Infusible grade short-term cell storage medium for mononuclear cells
|
US6734338B1
(en)
|
1997-11-14 |
2004-05-11 |
Cedars-Sinai Medical Center |
Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies
|
JP2001523468A
(en)
*
|
1997-11-14 |
2001-11-27 |
セダーシナイ メディカル センター |
Transfection and transfer of male germ cells for production of transgenic species
|
US7294755B1
(en)
|
1997-11-14 |
2007-11-13 |
Cedars-Sinai Medical Center |
Genetic modification of male germ cells for generation of transgenic species and genetic therapies
|
US6361642B1
(en)
|
1997-12-02 |
2002-03-26 |
Baxter International Inc. |
Heat and pressure-formed flexible containers
|
EP1034288A4
(en)
*
|
1997-12-04 |
2002-11-27 |
Univ Duke |
Methods of isolating and using cd7+cd34-lin-hematopoietic cells
|
US6059968A
(en)
*
|
1998-01-20 |
2000-05-09 |
Baxter International Inc. |
Systems for processing and storing placenta/umbilical cord blood
|
EP1060242A4
(en)
|
1998-01-23 |
2003-09-17 |
Imclone Systems Inc |
Purified populations of stem cells
|
US20020034819A1
(en)
*
|
1998-02-23 |
2002-03-21 |
Alan K. Smith |
Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
|
US8318495B1
(en)
|
1998-05-29 |
2012-11-27 |
Case Western Reserve University |
Hematopoietic progenitor cell gene transduction
|
US6451558B1
(en)
*
|
1998-08-03 |
2002-09-17 |
Novartis Ag |
Genes in the control of hematopoiesis
|
WO2000011139A1
(en)
*
|
1998-08-24 |
2000-03-02 |
T.Breeders, Inc. |
Cell population containing non-fetal hemangioblasts and method for producing same
|
AU5448099A
(en)
*
|
1998-09-02 |
2000-03-27 |
Chugai Seiyaku Kabushiki Kaisha |
Method for preparing cell fraction containing hematopoietic stem cells
|
US8297377B2
(en)
*
|
1998-11-20 |
2012-10-30 |
Vitruvian Exploration, Llc |
Method and system for accessing subterranean deposits from the surface and tools therefor
|
PT1137798E
(en)
*
|
1998-12-07 |
2009-02-20 |
Univ Duke |
A method of isolating stem cells
|
WO2000043499A2
(en)
*
|
1999-01-25 |
2000-07-27 |
Seattle Biomedical Research Institute |
ANTI-TRANSFORMING GROWTH FACTOR BETA (TGF-β) TREATED STEM CELL COMPOSITION AND METHOD
|
DE60016567T2
(en)
|
1999-02-03 |
2005-12-08 |
I.D.M. Immuno-Designed Molecules |
MACROPHAGE-BASED COMPOSITION WITH ANTI-INFECTIOUS AND HEMATOPOIETIC PROPERTIES AND THEIR METHOD OF PREPARATION
|
US6153113A
(en)
*
|
1999-02-22 |
2000-11-28 |
Cobe Laboratories, Inc. |
Method for using ligands in particle separation
|
US6238922B1
(en)
*
|
1999-02-26 |
2001-05-29 |
Stemcells, Inc. |
Use of collagenase in the preparation of neural stem cell cultures
|
US20050020524A1
(en)
*
|
1999-04-15 |
2005-01-27 |
Monash University |
Hematopoietic stem cell gene therapy
|
US20040258672A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Graft acceptance through manipulation of thymic regeneration
|
US20070274946A1
(en)
*
|
1999-04-15 |
2007-11-29 |
Norwood Immunoloty, Ltd. |
Tolerance to Graft Prior to Thymic Reactivation
|
US20040265285A1
(en)
*
|
1999-04-15 |
2004-12-30 |
Monash University |
Normalization of defective T cell responsiveness through manipulation of thymic regeneration
|
US20040259803A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Disease prevention by reactivation of the thymus
|
US20040241842A1
(en)
*
|
1999-04-15 |
2004-12-02 |
Monash University |
Stimulation of thymus for vaccination development
|
AUPR074500A0
(en)
*
|
2000-10-13 |
2000-11-09 |
Monash University |
Treatment of t cell disorders
|
US7759113B2
(en)
*
|
1999-04-30 |
2010-07-20 |
The General Hospital Corporation |
Fabrication of tissue lamina using microfabricated two-dimensional molds
|
US7371400B2
(en)
|
2001-01-02 |
2008-05-13 |
The General Hospital Corporation |
Multilayer device for tissue engineering
|
AU772484B2
(en)
*
|
1999-04-30 |
2004-04-29 |
Massachusetts General Hospital |
Fabrication of vascularized tissue using microfabricated two-dimensional molds
|
AU780468B2
(en)
*
|
1999-06-23 |
2005-03-24 |
Oregon Health And Science University |
Method for enhancing hematopoiesis
|
US6821513B1
(en)
|
1999-06-23 |
2004-11-23 |
Oregon Health & Science University |
Method for enhancing hematopoiesis
|
US8252280B1
(en)
|
1999-08-05 |
2012-08-28 |
Regents Of The University Of Minnesota |
MAPC generation of muscle
|
CA2381292C
(en)
|
1999-08-05 |
2016-05-24 |
Mcl Llc |
Multipotent adult stem cells and methods for isolation
|
US10638734B2
(en)
|
2004-01-05 |
2020-05-05 |
Abt Holding Company |
Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
|
WO2002064748A2
(en)
*
|
2001-02-14 |
2002-08-22 |
Furcht Leo T |
Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
|
US7015037B1
(en)
*
|
1999-08-05 |
2006-03-21 |
Regents Of The University Of Minnesota |
Multiponent adult stem cells and methods for isolation
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
US6749850B1
(en)
|
1999-08-18 |
2004-06-15 |
The General Hospital Corporation |
Methods, compositions and kits for promoting recovery from damage to the central nervous system
|
WO2001023528A1
(en)
*
|
1999-09-27 |
2001-04-05 |
University Of Florida Research Foundation |
Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
|
WO2001036589A2
(en)
*
|
1999-11-17 |
2001-05-25 |
University Of Rochester |
Human ex vivo immune system
|
US6790614B1
(en)
|
1999-11-19 |
2004-09-14 |
Novartis Ag |
Selectable cell surface marker genes
|
US7112576B1
(en)
|
1999-12-10 |
2006-09-26 |
Regents Of The University Of Minnesota |
Compositions and methods for cryopreservation of peripheral blood lymphocytes
|
EP1240318A4
(en)
*
|
1999-12-20 |
2004-12-08 |
Univ Massachusetts |
Embryonic or stem-like cells produced by cross species nuclear transplantation
|
AU2001247442B2
(en)
*
|
2000-03-15 |
2006-07-27 |
Children's Medical Center Corporation |
Systemic gene delivery vehicles for the treatment of tumors
|
US7129326B2
(en)
*
|
2000-04-14 |
2006-10-31 |
Genencor International, Inc. |
Methods for selective targeting
|
CA2405715C
(en)
*
|
2000-04-14 |
2011-11-15 |
Genencor International, Inc. |
Methods for selective targeting
|
US7776021B2
(en)
|
2000-04-28 |
2010-08-17 |
The Charles Stark Draper Laboratory |
Micromachined bilayer unit for filtration of small molecules
|
US8491884B2
(en)
|
2000-05-03 |
2013-07-23 |
Oncolytics Biotech Inc. |
Virus clearance of neoplastic cells from mixed cellular compositions
|
AR028039A1
(en)
|
2000-05-03 |
2003-04-23 |
Oncolytics Biotech Inc |
REMOVAL OF REOVIRUS FROM NEOPLASTIC CELLS INTERMEDIATE BY RAS FROM MIXED CELL COMPOSITIONS
|
AR028040A1
(en)
*
|
2000-05-03 |
2003-04-23 |
Oncolytics Biotech Inc |
REMOVAL OF NEOPLASTIC CELL VIRUSES FROM MIXED CELL COMPOSITIONS
|
US6828145B2
(en)
*
|
2000-05-10 |
2004-12-07 |
Cedars-Sinai Medical Center |
Method for the isolation of stem cells by immuno-labeling with HLA/MHC gene product marker
|
CA2412436C
(en)
*
|
2000-06-05 |
2013-05-21 |
The Trustees Of Columbia University In The City Of New York |
Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
|
FR2810045B1
(en)
*
|
2000-06-07 |
2004-09-03 |
Assist Publ Hopitaux De Paris |
METHOD FOR OBTAINING CELLULAR CELLULAR POPULATIONS OF MUSCLE ORIGIN AND USES THEREOF
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
US8044259B2
(en)
*
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
EP1978090A1
(en)
|
2000-08-09 |
2008-10-08 |
ES Cell International Pte Ltd. |
Pancreatic progenitor cells
|
US20060088512A1
(en)
*
|
2001-10-15 |
2006-04-27 |
Monash University |
Treatment of T cell disorders
|
WO2002057428A1
(en)
*
|
2000-10-30 |
2002-07-25 |
University Of Massachusetts |
Isolation of spore-like cells from tissues exposed to extreme conditions
|
KR20040029311A
(en)
*
|
2000-11-22 |
2004-04-06 |
제론 코포레이션 |
Tolerizing allografts of pluripotent stem cells
|
US6921665B2
(en)
|
2000-11-27 |
2005-07-26 |
Roslin Institute (Edinburgh) |
Selective antibody targeting of undifferentiated stem cells
|
US6576464B2
(en)
*
|
2000-11-27 |
2003-06-10 |
Geron Corporation |
Methods for providing differentiated stem cells
|
WO2002044345A1
(en)
*
|
2000-12-01 |
2002-06-06 |
The General Hospital Corporation |
Methods and products for manipulating hematopoietic stem cells
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
US20080152629A1
(en)
*
|
2000-12-06 |
2008-06-26 |
James Edinger |
Placental stem cell populations
|
DK1349918T3
(en)
|
2000-12-06 |
2014-11-10 |
Anthrogenesis Corp |
Method of collecting stem cells from placenta
|
US20030068792A1
(en)
*
|
2000-12-14 |
2003-04-10 |
Yiyou Chen |
Targeted enzymes
|
US20030147874A1
(en)
*
|
2000-12-14 |
2003-08-07 |
Volker Schellenberger |
Targeted enzyme prodrug therapy
|
US20080248544A1
(en)
*
|
2000-12-14 |
2008-10-09 |
Murray Christopher J |
Methods And Compositions For Grafting Functional Loops Into A Protein
|
US20030049689A1
(en)
*
|
2000-12-14 |
2003-03-13 |
Cynthia Edwards |
Multifunctional polypeptides
|
JP2005500977A
(en)
*
|
2000-12-19 |
2005-01-13 |
インサイト ストラテジー アンド マーケティング リミテッド |
Use of extracellular matrix degrading enzymes to improve cell transplantation
|
EP2336299A1
(en)
*
|
2001-02-14 |
2011-06-22 |
Anthrogenesis Corporation |
Post-partum mammalian placenta, its use and placental stem cells therefrom
|
US7723111B2
(en)
*
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
FR2821947B1
(en)
*
|
2001-03-12 |
2003-05-16 |
Canon Kk |
METHOD AND DEVICE FOR VALIDATING IMAGE DEFINING PARAMETERS
|
WO2002079457A1
(en)
*
|
2001-03-29 |
2002-10-10 |
Ixion Biotechnology, Inc. |
Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
|
US20030095952A1
(en)
*
|
2001-06-13 |
2003-05-22 |
Krause Diane S. |
Multi-organ engraftment with a single bone marrow-derived stem cell
|
JP4493882B2
(en)
*
|
2001-06-19 |
2010-06-30 |
株式会社カネカ |
Antigen and monoclonal antibody that distinguishes this antigen
|
EP1515707A4
(en)
*
|
2001-06-20 |
2005-10-19 |
Imclone Systems Inc |
Method of treating atherosclerosis and other inflammatory diseases
|
DE60223556T2
(en)
*
|
2001-08-10 |
2008-09-18 |
Imclone Systems, Inc. |
MEDICAL USE OF STEM CELLS EXPRESSING VEGFR-1
|
US20030049836A1
(en)
*
|
2001-08-15 |
2003-03-13 |
Phi-Wilson Janette T. |
Cell separation system
|
DE10144326B4
(en)
*
|
2001-09-10 |
2005-09-22 |
Siemens Ag |
Method and system for monitoring a tire air pressure
|
US20030134415A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Gruenberg Micheal L. |
Th1 cell adoptive immunotherapy
|
US20030134341A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Medcell Biologics, Llc. |
Th1 cell adoptive immunotherapy
|
US9969980B2
(en)
*
|
2001-09-21 |
2018-05-15 |
Garnet Biotherapeutics |
Cell populations which co-express CD49c and CD90
|
EP1435779A4
(en)
|
2001-09-24 |
2005-06-01 |
Sangamo Biosciences Inc |
Modulation of stem cells using zinc finger proteins
|
US20030119080A1
(en)
*
|
2001-10-15 |
2003-06-26 |
Mangano Joseph A. |
Strategies for the identification and isolation of cancer stem cells and non-cancerous stem cells
|
US7129034B2
(en)
*
|
2001-10-25 |
2006-10-31 |
Cedars-Sinai Medical Center |
Differentiation of whole bone marrow
|
US6759244B2
(en)
|
2001-11-08 |
2004-07-06 |
Art Institute Of New York And New Jersey, Inc. |
Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos
|
US20040224403A1
(en)
*
|
2001-12-07 |
2004-11-11 |
Robarts Research Institute |
Reconstituting hematopoietic cell function using human embryonic stem cells
|
US7799324B2
(en)
*
|
2001-12-07 |
2010-09-21 |
Geron Corporation |
Using undifferentiated embryonic stem cells to control the immune system
|
CA2469204A1
(en)
*
|
2001-12-07 |
2003-06-19 |
Regents Of The University Of Michigan |
Prospective identification and characterization of breast cancer stem cells
|
JP5364224B2
(en)
|
2001-12-07 |
2013-12-11 |
ジェロン・コーポレーション |
Hematopoietic cells derived from human embryonic stem cells
|
US7190781B2
(en)
*
|
2002-01-04 |
2007-03-13 |
Telefonaktiebolaget Lm Ericsson (Publ) |
Message transfer part point code mapping method and node
|
US7682803B2
(en)
|
2005-10-13 |
2010-03-23 |
Anthrogenesis Corporation |
Immunomodulation using placental stem cells
|
DK1487856T3
(en)
*
|
2002-03-04 |
2010-10-18 |
Imclone Llc |
KDR-specific human antibodies and their use
|
US20030175272A1
(en)
*
|
2002-03-07 |
2003-09-18 |
Medcell Biologics, Inc. |
Re-activated T-cells for adoptive immunotherapy
|
US20030199464A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
US20030215935A1
(en)
*
|
2002-05-14 |
2003-11-20 |
Coon David James |
Apparatus and method for isolating living cells from an encapsulated organ tissue sample
|
AU2003241107B2
(en)
*
|
2002-05-16 |
2009-09-03 |
Absorber Ab |
Method of isolating an endothelial cell and method of donor specific crossmatching
|
US6943021B2
(en)
*
|
2002-06-07 |
2005-09-13 |
Mattek Corporation |
Three dimensional vaginal tissue model containing immune cells
|
CA2489022C
(en)
|
2002-06-12 |
2012-10-16 |
Genencor International, Inc. |
Methods for improving a binding characteristic of a molecule
|
WO2004009758A2
(en)
*
|
2002-07-23 |
2004-01-29 |
Nanodiagnostics, Inc. |
Embryonic stem cell markers and uses thereof
|
US20110158966A1
(en)
*
|
2002-07-23 |
2011-06-30 |
Judith Seligman |
Stem cells characterized by expression of germline specific genes
|
US7635477B2
(en)
|
2002-07-25 |
2009-12-22 |
The General Hospital Corporation |
Parathyroid hormone receptor activation and stem and progenitor cell expansion
|
JP4750416B2
(en)
*
|
2002-07-25 |
2011-08-17 |
ザ ジェネラル ホスピタル コーポレイション |
Activation of parathyroid hormone receptor and proliferation of hematopoietic progenitor cells
|
US20040028661A1
(en)
*
|
2002-08-07 |
2004-02-12 |
Bartelmez Stephen H. |
Expansion of cells using thrombopoietin and anti-transforming growth factor-beta
|
US20060110375A1
(en)
*
|
2002-08-09 |
2006-05-25 |
Herbert Zech |
Method for producing cell lines and organs by means of differentiable cells
|
US20050271639A1
(en)
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
US20040077985A1
(en)
*
|
2002-09-03 |
2004-04-22 |
Donnie Rudd |
Method of replenishing cells damaged by treatment for cancer
|
US20040044300A1
(en)
*
|
2002-09-03 |
2004-03-04 |
Donnie Rudd |
Method of replenishing cells damaged by treatment for cancer
|
US9969977B2
(en)
|
2002-09-20 |
2018-05-15 |
Garnet Biotherapeutics |
Cell populations which co-express CD49c and CD90
|
JP4939055B2
(en)
|
2002-11-13 |
2012-05-23 |
トマス ジェファソン ユニバーシティ |
Compositions and methods for diagnosis and treatment of cancer
|
WO2004046312A2
(en)
*
|
2002-11-15 |
2004-06-03 |
The Board Of Trustees Of The University Of Illinois |
Methods for in vitro expansion of hematopoietic stem cells
|
CN1717177A
(en)
*
|
2002-11-26 |
2006-01-04 |
人类起源公司 |
Cytotherapeutics, cytotherapeutic units and methods for treatments using them
|
US20040110286A1
(en)
*
|
2002-12-06 |
2004-06-10 |
The John P. Robarts Research Institute |
Method for making hematopoietic cells
|
EP1589814B1
(en)
|
2003-01-16 |
2009-08-12 |
The General Hospital Corporation |
Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
|
NZ566132A
(en)
*
|
2003-02-13 |
2009-09-25 |
Anthrogenesis Corp |
Use of umbilical cord blood to treat inflammation, ParkinsonÆs disease or diabetes
|
CA2520861A1
(en)
*
|
2003-03-27 |
2004-10-14 |
Ixion Biotechnology, Inc. |
Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
|
EP1636351A4
(en)
|
2003-05-21 |
2007-04-04 |
Gen Hospital Corp |
Microfabricated compositions and processes for engineering tissues containing multiple cell types
|
CA2528669A1
(en)
*
|
2003-06-09 |
2005-01-20 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
EP1702062A2
(en)
*
|
2003-06-11 |
2006-09-20 |
Jan Remmereit |
Differentiation of stem cells for therapeutic use
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
US8153410B2
(en)
*
|
2003-07-07 |
2012-04-10 |
Fox Chase Cancer Center |
Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
|
US20060162014A1
(en)
*
|
2003-07-07 |
2006-07-20 |
Jaffe Eileen K |
Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
EP2927318B1
(en)
|
2003-08-08 |
2020-05-20 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US7569385B2
(en)
*
|
2003-08-14 |
2009-08-04 |
The Regents Of The University Of California |
Multipotent amniotic fetal stem cells
|
GB0321337D0
(en)
*
|
2003-09-11 |
2003-10-15 |
Massone Mobile Advertising Sys |
Method and system for distributing advertisements
|
WO2005027841A2
(en)
*
|
2003-09-16 |
2005-03-31 |
University Of North Carolina At Chapel Hill |
Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease
|
US7510877B2
(en)
|
2003-09-26 |
2009-03-31 |
The Regents Of The University Of Michigan |
Hematopoietic stem cell identification and isolation
|
EP1685236A4
(en)
*
|
2003-09-29 |
2008-01-23 |
Univ California |
Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration
|
AU2004291559B2
(en)
*
|
2003-11-19 |
2008-10-16 |
Australian Stem Cell Centre Limited |
Methods for producing blood products from pluripotent cells in cell culture
|
JP5089170B2
(en)
*
|
2003-12-02 |
2012-12-05 |
セルジーン コーポレイション |
Methods and compositions for the treatment and management of abnormal hemoglobinosis and anemia
|
US20080279812A1
(en)
*
|
2003-12-05 |
2008-11-13 |
Norwood Immunology, Ltd. |
Disease Prevention and Vaccination Prior to Thymic Reactivation
|
EP2319544A1
(en)
|
2004-01-16 |
2011-05-11 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
US20050232927A1
(en)
*
|
2004-02-03 |
2005-10-20 |
The Regents Of The University Of Michigan |
Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
|
AU2004316477B2
(en)
|
2004-02-11 |
2010-10-07 |
Aldagen, Inc. |
Stem cell populations and methods of use
|
AU2005219660B2
(en)
*
|
2004-03-09 |
2009-07-16 |
Absorber Ab |
Endothelial progenitor cells and methods of use thereof
|
EP1730161B1
(en)
*
|
2004-03-25 |
2010-09-08 |
California Institute Of Technology |
Hybridization chain reaction
|
US7622108B2
(en)
*
|
2004-04-23 |
2009-11-24 |
Bioe, Inc. |
Multi-lineage progenitor cells
|
DE602005027557D1
(en)
*
|
2004-04-23 |
2011-06-01 |
Bioe Llc |
MULTIPLE LINE Progenitor Cells
|
EP1756267A2
(en)
|
2004-05-14 |
2007-02-28 |
Becton, Dickinson and Company |
Stem cell populations and methods of use
|
US20080233100A1
(en)
*
|
2004-06-30 |
2008-09-25 |
Yiyou Chen |
Targeted enzymes
|
JP2008505650A
(en)
*
|
2004-07-12 |
2008-02-28 |
ソリン・グループ・イタリア・ソシエタ・ア・レスポンサビリタ・リミタータ |
Apparatus and method for growing human cells
|
PT1799844E
(en)
*
|
2004-09-10 |
2010-03-29 |
Genencor Int |
Methods for detecting targets
|
CN101044405B
(en)
*
|
2004-10-15 |
2015-06-10 |
金克克国际有限公司 |
Competitive differential screening
|
EP1799717B1
(en)
*
|
2004-10-22 |
2015-05-20 |
Danisco US Inc. |
Isolating human antibodies
|
EP1812555B1
(en)
|
2004-10-25 |
2015-04-22 |
Cellerant Therapeutics, Inc. |
Methods of expanding myeloid cell populations and uses thereof
|
JP5500773B2
(en)
|
2004-11-11 |
2014-05-21 |
ザ ジェネラル ホスピタル コーポレーション |
Activation of parathyroid hormone receptor and proliferation of stem and progenitor cells
|
PT1819358E
(en)
*
|
2004-11-18 |
2014-11-17 |
Imclone Llc |
Antibodies against vascular endothelial growth factor receptor-1
|
US20080044400A1
(en)
*
|
2004-12-09 |
2008-02-21 |
Volker Schellenberger |
Targeted enzyme prodrug therapy
|
GB0503918D0
(en)
*
|
2005-02-25 |
2005-04-06 |
Erasmus University |
Cell
|
US7727721B2
(en)
*
|
2005-03-08 |
2010-06-01 |
California Institute Of Technology |
Hybridization chain reaction amplification for in situ imaging
|
US20060252073A1
(en)
*
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
US20060269527A1
(en)
*
|
2005-05-26 |
2006-11-30 |
Australian Stem Cell Centre Limited |
Isolation of cells from bone
|
WO2006135886A2
(en)
*
|
2005-06-13 |
2006-12-21 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
AU2006259583A1
(en)
*
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
CA2615532C
(en)
|
2005-07-26 |
2016-06-28 |
Sangamo Biosciences, Inc. |
Targeted integration and expression of exogenous nucleic acid sequences
|
CN101313065A
(en)
*
|
2005-08-01 |
2008-11-26 |
纽珀滕索有限公司 |
Production of reprogrammed cells with restored potential
|
US20090035257A1
(en)
|
2005-08-25 |
2009-02-05 |
Repair Technologies, Inc. |
Devices, compositions and methods for the protection and repair of cells and tissues
|
US8481505B2
(en)
|
2005-09-12 |
2013-07-09 |
The Ohio State University Research Foundation |
Compositions and methods for the diagnosis and therapy of BCL2-associated cancers
|
ATE526975T1
(en)
*
|
2005-10-07 |
2011-10-15 |
California Inst Of Techn |
PKR ACTIVATION USING HYBRIDIZATION CHAIN REACTION
|
US7462485B2
(en)
*
|
2005-10-07 |
2008-12-09 |
Glaser Lawrence F |
Modified erythrocytes and uses thereof
|
WO2007053577A2
(en)
|
2005-10-31 |
2007-05-10 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
AU2006308847C1
(en)
|
2005-10-31 |
2012-05-10 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for treating and diagnosing cancer
|
US8637005B2
(en)
|
2005-11-07 |
2014-01-28 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
US20110076255A1
(en)
|
2005-11-07 |
2011-03-31 |
Pecora Andrew L |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
SI2441461T1
(en)
*
|
2005-11-07 |
2014-09-30 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
EP1974018A4
(en)
|
2005-12-08 |
2010-01-27 |
Univ Louisville Res Found |
Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
|
US9155762B2
(en)
*
|
2005-12-08 |
2015-10-13 |
University Of Louisville Research Foundation, Inc. |
Uses and isolation of stem cells from bone marrow
|
ZA200804718B
(en)
|
2005-12-29 |
2010-04-28 |
Anthrogenesis Corp |
Co-culture of placental stem cells and stem cells from a second source
|
ES2711278T3
(en)
|
2005-12-29 |
2019-04-30 |
Celularity Inc |
Populations of placental stem cells
|
JP5341525B2
(en)
*
|
2006-02-14 |
2013-11-13 |
セルラント セラピューティクス,インコーポレイティド |
Methods and compositions for enhancing hematopoietic stem cell engraftment
|
MY154677A
(en)
|
2006-03-07 |
2015-07-15 |
Shroff Geeta |
Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
|
US20100297087A1
(en)
*
|
2006-04-11 |
2010-11-25 |
Nanodiagnostics Israel., Ltd |
Pluripotent stem cells characterized by expression of germline specific genes
|
EP2010646A2
(en)
*
|
2006-04-14 |
2009-01-07 |
Carnegie Mellon University |
Cellular labeling and quantification for nuclear magnetic resonance techniques
|
AU2007314614A1
(en)
*
|
2006-04-14 |
2008-05-08 |
Celsense, Inc. |
Methods for assessing cell labeling
|
WO2007121443A2
(en)
*
|
2006-04-17 |
2007-10-25 |
Bioe, Inc. |
Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
|
AU2007285483B2
(en)
|
2006-05-11 |
2011-12-22 |
Regenics As |
Administration of cells and cellular extracts for rejuvenation
|
US8557295B2
(en)
|
2006-05-11 |
2013-10-15 |
Regenics As |
Use of cellular extracts for skin rejuvenation
|
US20080050814A1
(en)
*
|
2006-06-05 |
2008-02-28 |
Cryo-Cell International, Inc. |
Procurement, isolation and cryopreservation of fetal placental cells
|
WO2007146105A2
(en)
*
|
2006-06-05 |
2007-12-21 |
Cryo-Cell International, Inc. |
Procurement, isolation and cryopreservation of fetal placental cells
|
KR20090043559A
(en)
|
2006-08-15 |
2009-05-06 |
에이전시 포 사이언스, 테크놀로지 앤드 리서치 |
Mesenchymal stem cell conditioned medium
|
US8785193B2
(en)
|
2006-09-14 |
2014-07-22 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Dissection tool and methods of use
|
US20120269774A1
(en)
*
|
2006-09-21 |
2012-10-25 |
Medistem Laboratories, Inc |
Allogeneic stem cell transplants in non-conditioned recipients
|
CA2700573C
(en)
|
2006-09-26 |
2016-11-22 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
WO2008066658A2
(en)
*
|
2006-11-03 |
2008-06-05 |
The Trustees Of Princeton University |
Engineered cellular pathways for programmed autoregulation of differentiation
|
JP5537153B2
(en)
*
|
2006-11-03 |
2014-07-02 |
アストロム バイオサイエンシーズ, インコーポレイテッド |
Mixed cell populations for tissue repair and isolation techniques for cell processing
|
WO2008063675A2
(en)
*
|
2006-11-24 |
2008-05-29 |
Regents Of The University Of Minnesota |
Endodermal progenitor cells
|
WO2008070861A2
(en)
*
|
2006-12-07 |
2008-06-12 |
Cellerant Therapeutics Inc. |
Methods and compositions for treating systemic lupus erythematosus
|
US20100172882A1
(en)
*
|
2007-01-11 |
2010-07-08 |
Glazer Peter M |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
AU2008206884B2
(en)
|
2007-01-18 |
2012-07-05 |
Glykos Finland Oy |
Novel methods and reagents directed to production of cells
|
EP2115460A4
(en)
|
2007-01-18 |
2010-01-13 |
Suomen Punainen Risti Veripalv |
Novel carbohydrate from human cells and methods for analysis and modification thereof
|
US8148147B2
(en)
*
|
2007-01-24 |
2012-04-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
US10494607B2
(en)
*
|
2007-02-12 |
2019-12-03 |
Celularity, Inc. |
CD34+,CD45−placental stem cell-enriched cell populations
|
NZ578819A
(en)
|
2007-02-12 |
2012-02-24 |
Anthrogenesis Corp |
Treatment of inflammatory diseases using placental stem cells
|
DK2918598T3
(en)
|
2007-02-28 |
2019-04-29 |
The Govt Of U S A As Represented By The Secretary Of The Dept Of Health And Human Services |
Brachyury polypeptides and methods of use
|
WO2008106658A2
(en)
*
|
2007-03-01 |
2008-09-04 |
California Institute Of Technology |
TRIGGERED RNAi
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
US20100172830A1
(en)
*
|
2007-03-29 |
2010-07-08 |
Cellx Inc. |
Extraembryonic Tissue cells and method of use thereof
|
EP2607477B1
(en)
|
2007-05-03 |
2020-09-23 |
The Brigham and Women's Hospital, Inc. |
Multipotent stem cells and uses thereof
|
US8574567B2
(en)
*
|
2007-05-03 |
2013-11-05 |
The Brigham And Women's Hospital, Inc. |
Multipotent stem cells and uses thereof
|
JP2010525836A
(en)
*
|
2007-05-04 |
2010-07-29 |
ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ |
Ex vivo expansion of human hematopoietic stem cells
|
WO2008144562A1
(en)
|
2007-05-16 |
2008-11-27 |
California Institute Of Technology |
A versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways
|
TWM322542U
(en)
*
|
2007-05-23 |
2007-11-21 |
Universal Scient Ind Co Ltd |
Testing machine
|
US8354370B2
(en)
*
|
2007-06-15 |
2013-01-15 |
Garnet Biotherapeutics, Inc. |
Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders
|
EP2170975B1
(en)
*
|
2007-07-10 |
2018-05-02 |
Carnegie Mellon University |
Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
|
US20090029463A1
(en)
*
|
2007-07-25 |
2009-01-29 |
Bioe, Inc. |
Differentiation of Multi-Lineage Progenitor Cells to Chondrocytes
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
KR101644659B1
(en)
*
|
2007-09-26 |
2016-08-01 |
안트로제네시스 코포레이션 |
Angiogenic cells from human placental perfusate
|
EP3524253A1
(en)
|
2007-09-28 |
2019-08-14 |
Celularity, Inc. |
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
|
EP2214497A4
(en)
*
|
2007-10-30 |
2010-11-24 |
Univ Louisville Res Found |
Uses and isolation of very small embryonic-like (vsel) stem cells
|
WO2009058983A2
(en)
*
|
2007-10-30 |
2009-05-07 |
University Of Louisville Research Foundation, Inc. |
Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor
|
KR20160040739A
(en)
*
|
2007-11-07 |
2016-04-14 |
안트로제네시스 코포레이션 |
Use of umbilical cord blood in the treatment of premature birth complications
|
WO2009099961A2
(en)
|
2008-01-31 |
2009-08-13 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Engineered antibody constant domain molecules
|
US8497364B2
(en)
*
|
2008-02-27 |
2013-07-30 |
California Institute Of Technology |
Triggered RNAi
|
EP2479260B1
(en)
|
2008-03-17 |
2016-01-06 |
Agency For Science, Technology And Research |
Microcarriers for stem cell culture
|
WO2009120368A2
(en)
|
2008-03-28 |
2009-10-01 |
Stemcyte, Inc. |
Treatment of brain damage using umbilical cord blood cells
|
US20110110863A1
(en)
*
|
2008-05-02 |
2011-05-12 |
Celsense, Inc. |
Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
|
ES2613965T3
(en)
|
2008-05-09 |
2017-05-29 |
Regenics As |
Cell extracts
|
US20100021904A1
(en)
*
|
2008-05-21 |
2010-01-28 |
Pierce Niles A |
Shielded cross-linking probes
|
EP2294187A2
(en)
*
|
2008-05-21 |
2011-03-16 |
BioE LLC |
Differentiation of multi-lineage progenitor cells to pancreatic cells
|
US20100021901A1
(en)
*
|
2008-05-22 |
2010-01-28 |
Peng Yin |
Compositions and methods for detecting analytes
|
US8241854B2
(en)
|
2008-05-22 |
2012-08-14 |
California Institute Of Technology |
Triggered RNAi
|
US8632768B2
(en)
|
2008-05-30 |
2014-01-21 |
University Of Louisville Research Foundation, Inc. |
Human facilitating cells
|
US11291686B2
(en)
|
2008-05-30 |
2022-04-05 |
University Of Louisville Research Foundation, Inc. |
Human facilitating cells
|
US8680020B2
(en)
|
2008-07-15 |
2014-03-25 |
Academia Sinica |
Glycan arrays on PTFE-like aluminum coated glass slides and related methods
|
DK2330889T3
(en)
|
2008-08-20 |
2017-01-30 |
Anthrogenesis Corp |
Improved cell composition and process for making the same
|
CA2734237C
(en)
|
2008-08-20 |
2019-07-02 |
Anthrogenesis Corporation |
Treatment of stroke using isolated placental cells
|
CA2734446C
(en)
|
2008-08-22 |
2017-06-20 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
AU2009294850B2
(en)
|
2008-09-22 |
2015-07-02 |
Oregon Health & Science University |
Methods for detecting a Mycobacterium tuberculosis infection
|
TWI506037B
(en)
|
2008-09-26 |
2015-11-01 |
Oncomed Pharm Inc |
Frizzled-binding agents and uses thereof
|
JP5836125B2
(en)
|
2008-10-16 |
2015-12-24 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
Fully human antibodies against high molecular weight melanoma-related antigens and uses thereof
|
KR20110086176A
(en)
|
2008-11-19 |
2011-07-27 |
안트로제네시스 코포레이션 |
Amnion derived adherent cells
|
NZ602569A
(en)
*
|
2008-11-21 |
2014-03-28 |
Anthrogenesis Corp |
Treatment of diseases, disorders or conditions of the lung using placental cells
|
JP5705127B2
(en)
*
|
2008-12-03 |
2015-04-22 |
アモーサイト インコーポレイテッド |
Infarct region perfusion improving composition and method of repairing vascular injury
|
US20110250184A1
(en)
|
2008-12-16 |
2011-10-13 |
Onconova Therapeutics ,Inc. |
Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents in human
|
WO2010099472A2
(en)
|
2009-02-27 |
2010-09-02 |
The U.S.A. Of America, As Represented By The Secretary, Department Of Health And Human Services |
Spanx-b polypeptides and their use
|
US20100239539A1
(en)
*
|
2009-03-23 |
2010-09-23 |
Sing George L |
Methods for promoting differentiation and differentiation efficiency
|
JP2012531916A
(en)
|
2009-07-02 |
2012-12-13 |
アンソロジェネシス コーポレーション |
Method for producing red blood cells without using feeder cells
|
ES2546663T3
(en)
|
2009-07-15 |
2015-09-25 |
Calimmune Inc. |
Dual vector for inhibition of human immunodeficiency virus
|
AU2010276201B2
(en)
|
2009-07-21 |
2013-10-17 |
Abt Holding Company |
Use of stem cells to reduce leukocyte extravasation
|
EP2462230B1
(en)
|
2009-08-03 |
2015-07-15 |
Recombinetics, Inc. |
Methods and compositions for targeted gene modification
|
US20110268810A1
(en)
|
2009-11-02 |
2011-11-03 |
Yale University |
Polymeric materials loaded with mutagenic and recombinagenic nucleic acids
|
BR112012011183A2
(en)
|
2009-11-12 |
2015-09-15 |
Vbi Technologies Llc |
isolated spore-like cell subpopulation and method for isolating a spore-like cell subpopulation
|
EP2501397B1
(en)
|
2009-11-20 |
2017-10-04 |
Oregon Health and Science University |
Methods for producing an immune response to tuberculosis
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
TWI535445B
(en)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt antagonists and methods of treatment and screening
|
WO2011094181A1
(en)
|
2010-01-26 |
2011-08-04 |
Anthrogenesis Corporation |
Treatment of bone-related cancers using placental stem cells
|
WO2011106521A1
(en)
|
2010-02-25 |
2011-09-01 |
Abt Holding Company |
Modulation of macrophage activation
|
CN102971337B
(en)
|
2010-04-01 |
2016-09-21 |
昂考梅德药品有限公司 |
FZ combines medicament and application thereof
|
HUE029144T2
(en)
|
2010-04-07 |
2017-02-28 |
Anthrogenesis Corp |
Angiogenesis using placental stem cells
|
US9746459B2
(en)
|
2010-04-08 |
2017-08-29 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Antigen presenting cell assay
|
WO2011127113A1
(en)
|
2010-04-08 |
2011-10-13 |
Anthrogenesis Corporation |
Treatment of sarcoidosis using placental stem cells
|
CA2795403C
(en)
|
2010-04-08 |
2019-01-15 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
B-cell antigen presenting cell assay
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
US20110293585A1
(en)
|
2010-04-21 |
2011-12-01 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
WO2011133803A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
JP5841322B2
(en)
|
2010-04-22 |
2016-01-13 |
オレゴン ヘルス アンド サイエンス ユニバーシティ |
Fumaryl acetoacetate hydrolase (FAH) deficient pig and use thereof
|
SI2561078T1
(en)
|
2010-04-23 |
2019-01-31 |
Cold Spring Harbor Laboratory |
NOVEL STRUCTURALLY DESIGNED shRNAs
|
US8658780B2
(en)
|
2010-05-18 |
2014-02-25 |
California Institute Of Technology |
Triggered covalent probes for imaging and silencing genetic expression
|
EP2582793B1
(en)
|
2010-06-15 |
2017-09-06 |
Cellular Dynamics International, Inc. |
A compendium of ready-built stem cell models for interrogation of biological response
|
ES2695899T3
(en)
|
2010-06-16 |
2019-01-11 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Antibodies against endoplasmin and its use
|
CA2804595C
(en)
|
2010-07-07 |
2018-11-13 |
Cellular Dynamics International, Inc. |
Endothelial cell production by programming
|
CN103097520B
(en)
|
2010-07-13 |
2017-12-05 |
人类起源公司 |
The method for producing NK
|
US9834439B2
(en)
|
2010-07-20 |
2017-12-05 |
California Institute Of Technology |
Biomolecular self-assembly
|
US8962241B2
(en)
|
2010-07-20 |
2015-02-24 |
California Institute Of Technology |
Triggered molecular geometry based bioimaging probes
|
US8877438B2
(en)
|
2010-07-20 |
2014-11-04 |
California Institute Of Technology |
Self-assembled polynucleotide structure
|
JP6047489B2
(en)
|
2010-08-12 |
2016-12-21 |
フェイト セラピューティクス,インコーポレイテッド |
Improved hematopoietic stem and progenitor cell therapy
|
US9725689B2
(en)
|
2010-10-08 |
2017-08-08 |
Terumo Bct, Inc. |
Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
US8574899B2
(en)
|
2010-12-22 |
2013-11-05 |
Vladimir B Serikov |
Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
|
US20140038842A1
(en)
|
2010-12-28 |
2014-02-06 |
Xoma Technology |
Cell surface display using pdz domains
|
AU2011352036A1
(en)
|
2010-12-31 |
2013-07-18 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
EP2673358B1
(en)
|
2011-02-08 |
2019-01-09 |
FUJIFILM Cellular Dynamics, Inc. |
Hematopoietic precursor cell production by programming
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
ES2666550T3
(en)
|
2011-04-19 |
2018-05-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies specific for glypican 3 and their use
|
CN113559126A
(en)
|
2011-06-01 |
2021-10-29 |
人类起源公司 |
Treatment of pain using placental stem cells
|
KR101955053B1
(en)
|
2011-06-06 |
2019-03-06 |
리제네시스 비브이비에이 |
Expansion of stem cells in hollow fiber bioreactors
|
CA2838749A1
(en)
|
2011-06-10 |
2012-12-13 |
Bluebird Bio, Inc. |
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
|
EP2732038B1
(en)
|
2011-07-15 |
2018-09-05 |
The General Hospital Corporation |
Methods of transcription activator like effector assembly
|
EP2747551B1
(en)
|
2011-08-26 |
2020-02-12 |
Yecuris Corporation |
Fumarylacetoacetate hydrolase (fah)-deficient and immunodeficient rats and uses thereof
|
US9925221B2
(en)
|
2011-09-09 |
2018-03-27 |
Celularity, Inc. |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
WO2013043196A1
(en)
|
2011-09-23 |
2013-03-28 |
Bluebird Bio, Inc. |
Improved gene therapy methods
|
KR102011532B1
(en)
|
2011-09-30 |
2019-08-16 |
블루버드 바이오, 인코포레이티드. |
Compounds for improved viral transduction
|
US9452186B2
(en)
|
2011-12-02 |
2016-09-27 |
Fate Therapeutics, Inc. |
Enhanced stem cell composition
|
EP3381456A1
(en)
|
2011-12-02 |
2018-10-03 |
Fate Therapeutics, Inc. |
Improved methods for treating ischemia
|
TWI443107B
(en)
|
2011-12-29 |
2014-07-01 |
Ind Tech Res Inst |
Humanized anti-human cd34 monoclonal antibody and uses thereof
|
EP2825557B1
(en)
|
2012-03-16 |
2017-06-28 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Soluble engineered monomeric fc
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
WO2015065716A1
(en)
|
2013-10-15 |
2015-05-07 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
WO2013181543A1
(en)
|
2012-06-01 |
2013-12-05 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
High-affinity monoclonal antibodies to glypican-3 and use thereof
|
US10016463B2
(en)
|
2012-08-01 |
2018-07-10 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
|
IN2015DN00934A
(en)
|
2012-08-01 |
2015-06-12 |
United Therapeutics Corp |
|
CA2880701A1
(en)
|
2012-08-18 |
2014-02-27 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
WO2014031476A1
(en)
|
2012-08-21 |
2014-02-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin domain-specific monoclonal antibodies and use thereof
|
AU2013324049B2
(en)
|
2012-09-27 |
2017-09-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin antibodies and methods for eliciting potent antitumor activity
|
CN104768579A
(en)
|
2012-10-23 |
2015-07-08 |
昂科梅德制药有限公司 |
Methods of treating neuroendocrine tumors using Wnt pathway-binding agents
|
CN104955943B
(en)
|
2012-11-27 |
2018-09-25 |
儿童医疗中心有限公司 |
The distal ends the targeting BCL11A controlling element induced again for fetal hemoglobin
|
EP2928449B1
(en)
|
2012-12-10 |
2018-08-22 |
Regenics AS |
Use of egg cellular extracts for skin rejuvenation
|
KR102466885B1
(en)
|
2013-01-09 |
2022-11-11 |
유나이티드 세러퓨틱스 코오포레이션 |
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
|
WO2014120714A1
(en)
|
2013-01-30 |
2014-08-07 |
Cornell University |
Compositions and methods for the expansion of stem cells
|
EP2950885B1
(en)
|
2013-02-04 |
2018-11-21 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a wnt pathway inhibitor
|
AU2014215458A1
(en)
|
2013-02-05 |
2015-08-13 |
Anthrogenesis Corporation |
Natural killer cells from placenta
|
CA2901747A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
US9943545B2
(en)
|
2013-03-15 |
2018-04-17 |
Fate Therapeutics, Inc. |
Stem cell culture media and methods of enhancing cell survival
|
US10851412B2
(en)
|
2013-03-15 |
2020-12-01 |
Fate Therapeutics, Inc. |
Cell potency assay for therapeutic potential
|
US10266807B2
(en)
|
2013-04-03 |
2019-04-23 |
FUJIFILM Cellular Dynamics, Inc. |
Methods and compositions for culturing endoderm progenitor cells in suspension
|
HUE052516T2
(en)
|
2013-04-12 |
2021-05-28 |
Houston Methodist Hospital |
Improving organs for transplantation
|
AU2014266935B2
(en)
|
2013-04-30 |
2020-06-11 |
Katholieke Universiteit Leuven |
Cell therapy for myelodysplastic syndromes
|
US9758763B2
(en)
|
2013-05-29 |
2017-09-12 |
The Regents Of The University Of California |
Methods and compositions for somatic cell proliferation and viability
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
US9856472B2
(en)
|
2013-07-01 |
2018-01-02 |
California Institute Of Technology |
Small conditional RNAs
|
CA2923579C
(en)
|
2013-09-06 |
2023-09-05 |
Academia Sinica |
Human inkt cell activation using glycolipids with altered glycosyl groups
|
JP6633522B2
(en)
|
2013-11-16 |
2020-01-22 |
テルモ ビーシーティー、インコーポレーテッド |
Cell growth in bioreactors
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
WO2016114819A1
(en)
|
2015-01-16 |
2016-07-21 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
TW201620939A
(en)
|
2014-01-16 |
2016-06-16 |
中央研究院 |
Compositions and methods for treatment and detection of cancers
|
JP6783143B2
(en)
|
2014-03-25 |
2020-11-11 |
テルモ ビーシーティー、インコーポレーテッド |
Passive replenishment of medium
|
JP6562942B2
(en)
|
2014-03-27 |
2019-08-28 |
アカデミア シニカAcademia Sinica |
Reactive labeled compounds and uses thereof
|
WO2015164228A1
(en)
|
2014-04-21 |
2015-10-29 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
KR102390629B1
(en)
|
2014-04-25 |
2022-04-26 |
칠드런'즈 메디컬 센터 코포레이션 |
Compositions and methods to treating hemoglobinopathies
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
US10272019B2
(en)
|
2014-05-09 |
2019-04-30 |
Yale University |
Topical formulation of hyperbranched polyglycerol-coated particles thereof
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
AU2015267045B2
(en)
|
2014-05-27 |
2021-02-25 |
Academia Sinica |
Anti-HER2 glycoantibodies and uses thereof
|
WO2015184008A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Fucosidase from bacteroides and methods using the same
|
JP2017518989A
(en)
|
2014-05-27 |
2017-07-13 |
アカデミア シニカAcademia Sinica |
Anti-CD20 glycoengineered antibody group and use thereof
|
TWI732738B
(en)
|
2014-05-28 |
2021-07-11 |
中央研究院 |
Anti-tnf-alpha glycoantibodies and uses thereof
|
US11278572B2
(en)
|
2014-07-18 |
2022-03-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells
|
CN106999578B
(en)
|
2014-07-31 |
2022-03-04 |
美国政府(由卫生和人类服务部的部长所代表) |
Human monoclonal antibodies against EPHA4 and uses thereof
|
CA2960712A1
(en)
|
2014-09-08 |
2016-03-17 |
Academia Sinica |
Human inkt cell activation using glycolipids
|
JP6796059B2
(en)
|
2014-09-12 |
2020-12-02 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
WNT signaling agonist molecule
|
CN106715676A
(en)
|
2014-09-26 |
2017-05-24 |
泰尔茂比司特公司 |
Scheduled feed
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
JP6779887B2
(en)
|
2015-01-24 |
2020-11-04 |
アカデミア シニカAcademia Sinica |
New glycan conjugate and how to use it
|
US20180112180A1
(en)
|
2015-01-26 |
2018-04-26 |
Fate Therapeutics, Inc. |
Cells with increased immuno-regulatory properties and methods for their use and manufacture
|
EP3763814A1
(en)
|
2015-05-08 |
2021-01-13 |
The Children's Medical Center Corporation |
Targeting bcl11a enhancer functional regions for fetal hemoglobin reinduction
|
WO2016187594A1
(en)
|
2015-05-21 |
2016-11-24 |
Harpoon Therapeutics, Inc. |
Trispecific binding proteins and methods of use
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
US20180214488A1
(en)
|
2015-07-20 |
2018-08-02 |
Angiocrine Bioscience, Inc. |
Methods and compositions for stem cell transplantation
|
KR20180033537A
(en)
|
2015-07-21 |
2018-04-03 |
더 칠드런스 메디칼 센터 코포레이션 |
PD-L1 expressing hematopoietic stem cells and uses
|
US11312940B2
(en)
|
2015-08-31 |
2022-04-26 |
University Of Louisville Research Foundation, Inc. |
Progenitor cells and methods for preparing and using the same
|
US10935544B2
(en)
|
2015-09-04 |
2021-03-02 |
Obi Pharma, Inc. |
Glycan arrays and method of use
|
EP3362074B1
(en)
|
2015-10-16 |
2023-08-09 |
President and Fellows of Harvard College |
Regulatory t cell pd-1 modulation for regulating t cell effector immune responses
|
BR112018016450A2
(en)
|
2016-02-12 |
2018-12-26 |
Bluebird Bio Inc |
vcn enhancer compositions and methods of using them
|
WO2017139561A1
(en)
|
2016-02-12 |
2017-08-17 |
Bluebird Bio, Inc. |
Vcn enhancer compositions and methods of using the same
|
US20200308590A1
(en)
|
2016-02-16 |
2020-10-01 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
JP2019508037A
(en)
|
2016-02-16 |
2019-03-28 |
イェール ユニバーシティーYale Universit |
Compositions for enhancing targeted gene editing and methods of use thereof
|
WO2017147212A1
(en)
|
2016-02-22 |
2017-08-31 |
The Regents Of The University Of California |
Compositions and methods for imaging cell populations
|
EP3423568A4
(en)
|
2016-03-04 |
2019-11-13 |
University Of Louisville Research Foundation, Inc. |
Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (vsels)
|
CN109195996A
(en)
|
2016-03-08 |
2019-01-11 |
中央研究院 |
The modularity synthetic method of N- glycan and its array
|
KR20190080825A
(en)
|
2016-03-21 |
2019-07-08 |
다나-파버 캔서 인스티튜트 인크. |
T-cell dysfunction state-specific gene expression regulators and their uses
|
US10980894B2
(en)
|
2016-03-29 |
2021-04-20 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
CN109311995A
(en)
|
2016-03-29 |
2019-02-05 |
台湾浩鼎生技股份有限公司 |
Antibody, pharmaceutical composition and method
|
EP3436035A4
(en)
|
2016-03-29 |
2019-10-23 |
SmsBiotech, Inc. |
Compositions and methods for using small mobile stem cells
|
BR112018071683A2
(en)
|
2016-04-22 |
2019-02-19 |
Obi Pharma, Inc. |
method for treating breast cancer, method for treating a tumor in a patient, method for treating an individual suffering from cancer by immunotherapy, method for inducing / improving an immune response in an individual, method for improving obi-822 induced vaccine by immune response in an individual in need thereof, method for identifying a patient suitable for cancer therapy, and method for determining a patient's cancer treatment prognosis or drug response
|
WO2017196847A1
(en)
|
2016-05-10 |
2017-11-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Variable new antigen receptor (vnar) antibodies and antibody conjugates targeting tumor and viral antigens
|
US11623958B2
(en)
|
2016-05-20 |
2023-04-11 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment CD3 binding proteins
|
EA201892693A1
(en)
|
2016-05-20 |
2019-04-30 |
Харпун Терапьютикс, Инк. |
PROTEINS CONTAINING A SINGLE-BANDY VARIABLE FRAGMENT, CONNECTING CD3
|
US10100106B2
(en)
|
2016-05-20 |
2018-10-16 |
Harpoon Therapeutics, Inc. |
Single domain serum albumin binding protein
|
WO2017214182A1
(en)
|
2016-06-07 |
2017-12-14 |
The United States Of America. As Represented By The Secretary, Department Of Health & Human Services |
Fully human antibody targeting pdi for cancer immunotherapy
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
EP3481843B1
(en)
|
2016-07-05 |
2022-01-26 |
California Institute of Technology |
Fractional initiator hybridization chain reaction
|
KR20230117482A
(en)
|
2016-07-27 |
2023-08-08 |
오비아이 파머 인코퍼레이티드 |
Immunogenic/therapeutic glycan compositions and uses thereof
|
KR102528998B1
(en)
|
2016-07-29 |
2023-05-03 |
오비아이 파머 인코퍼레이티드 |
Human Antibodies, Pharmaceutical Compositions and Methods
|
EP3494135A1
(en)
|
2016-08-02 |
2019-06-12 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Monoclonal antibodies targeting glypican-2 (gpc2) and use thereof
|
CA3034057A1
(en)
|
2016-08-22 |
2018-03-01 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
CA3034617A1
(en)
|
2016-08-30 |
2018-03-08 |
California Institute Of Technology |
Immunohistochemistry via hybridization chain reaction
|
JP7179723B2
(en)
|
2016-10-24 |
2022-11-29 |
ユナイテッド セラピューティクス コーポレイション |
Enhancing the Immunomodulatory Properties of MSCs by Treprostinil
|
KR20190077103A
(en)
|
2016-11-21 |
2019-07-02 |
오비아이 파머 인코퍼레이티드 |
Conjugated biological molecules, pharmaceutical compositions and methods
|
KR102275008B1
(en)
|
2016-11-23 |
2021-07-13 |
하푼 테라퓨틱스, 인크. |
prostate specific membrane antigen binding protein
|
KR20190087539A
(en)
|
2016-11-23 |
2019-07-24 |
하푼 테라퓨틱스, 인크. |
PSMA-targeted triple specific proteins and methods of use
|
EP3548035A4
(en)
|
2016-11-30 |
2020-07-22 |
Case Western Reserve University |
Combinations of 15-pgdh inhibitors with corcosteroids and/or tnf inhibitors and uses thereof
|
WO2018119279A1
(en)
|
2016-12-21 |
2018-06-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies specific for flt3 and uses thereof
|
CN110573154A
(en)
|
2017-02-06 |
2019-12-13 |
卡斯西部储备大学 |
Compositions and methods for modulating short-chain dehydrogenase activity
|
US11499149B2
(en)
|
2017-02-15 |
2022-11-15 |
2Seventy Bio, Inc. |
Donor repair templates multiplex genome editing
|
EP3589662A4
(en)
|
2017-02-28 |
2020-12-30 |
Harpoon Therapeutics, Inc. |
Inducible monovalent antigen binding protein
|
US11261441B2
(en)
|
2017-03-29 |
2022-03-01 |
Bluebird Bio, Inc. |
Vectors and compositions for treating hemoglobinopathies
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
EP3656841A1
(en)
|
2017-03-31 |
2020-05-27 |
Terumo BCT, Inc. |
Cell expansion
|
US20200113821A1
(en)
|
2017-04-04 |
2020-04-16 |
Yale University |
Compositions and methods for in utero delivery
|
EP3619299A1
(en)
|
2017-05-03 |
2020-03-11 |
BioMarin Pharmaceutical Inc. |
Improved lentiviruses for transduction of hematopoietic stem cells.
|
WO2018209298A1
(en)
|
2017-05-12 |
2018-11-15 |
Harpoon Therapeutics, Inc. |
Mesothelin binding proteins
|
JP7209936B2
(en)
|
2017-05-12 |
2023-01-23 |
ハープーン セラピューティクス,インク. |
MSLN-targeting trispecific proteins and methods of use thereof
|
US11389480B2
(en)
|
2017-05-19 |
2022-07-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibody targeting TNFR2 for cancer immunotherapy
|
US11788087B2
(en)
|
2017-05-25 |
2023-10-17 |
The Children's Medical Center Corporation |
BCL11A guide delivery
|
AU2018281830B2
(en)
|
2017-06-09 |
2023-11-02 |
Agonox, Inc. |
Utilization of CD39 and CD103 for identification of human tumor reactive cells for treatment of cancer
|
WO2019005208A1
(en)
|
2017-06-30 |
2019-01-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human mesothelin antibodies and uses in cancer therapy
|
WO2019006280A1
(en)
|
2017-06-30 |
2019-01-03 |
Lentigen Technology, Inc. |
Human monoclonal antibodies specific for cd33 and methods of their use
|
WO2019060708A1
(en)
|
2017-09-22 |
2019-03-28 |
The Children's Medical Center Corporation |
Treatment of type 1 diabetes and autoimmune diseases or disorders
|
CA3078799A1
(en)
|
2017-10-13 |
2019-04-18 |
Harpoon Therapeutics, Inc. |
B cell maturation antigen binding proteins
|
US11136403B2
(en)
|
2017-10-13 |
2021-10-05 |
Harpoon Therapeutics, Inc. |
Trispecific proteins and methods of use
|
US11203645B2
(en)
|
2018-06-27 |
2021-12-21 |
Obi Pharma, Inc. |
Glycosynthase variants for glycoprotein engineering and methods of use
|
EP3813861A4
(en)
|
2018-06-27 |
2022-08-10 |
Juvena Therapeutics, Inc. |
Heparin-associated polypeptides and uses thereof
|
CA3105694A1
(en)
|
2018-07-12 |
2020-01-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Affinity matured cd22-specific monoclonal antibody and uses thereof
|
US20210292428A1
(en)
|
2018-08-08 |
2021-09-23 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
High affinity monoclonal antibodies targeting glypican-2 and uses thereof
|
MX2021002266A
(en)
|
2018-08-31 |
2021-05-27 |
Univ Yale |
Compositions and methods for enhancing triplex and nuclease-based gene editing.
|
US20210340280A1
(en)
|
2018-08-31 |
2021-11-04 |
Yale University |
Compositions and methods for enhancing donor oligonucleotide-based gene editing
|
CN113286817A
(en)
|
2018-09-25 |
2021-08-20 |
哈普恩治疗公司 |
DLL3 binding proteins and methods of use
|
US20220002435A1
(en)
|
2018-10-02 |
2022-01-06 |
Immunome, Inc. |
Antibodies targeting epn1
|
WO2020082076A1
(en)
|
2018-10-19 |
2020-04-23 |
Board Of Regents, The University Of Texas System |
Engineered long interspersed element (line) transposons and methods of use thereof
|
MA55147A
(en)
|
2018-11-21 |
2021-09-29 |
Univ Texas |
COMPOSITIONS AND METHODS FOR MODULATING SHORT CHAIN DEHYDROGENASE ACTIVITY
|
WO2020113025A1
(en)
|
2018-11-28 |
2020-06-04 |
Milica Radisic |
Methods for tissue generation
|
WO2020112195A1
(en)
|
2018-11-30 |
2020-06-04 |
Yale University |
Compositions, technologies and methods of using plerixafor to enhance gene editing
|
US20220064324A1
(en)
|
2019-01-08 |
2022-03-03 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Cross species single domain antibodies targeting mesothelin for treating solid tumors
|
US20220098323A1
(en)
|
2019-01-22 |
2022-03-31 |
The United States Of America,As Represented By The Secretary,Department Of Health And Human Services |
High affinity monoclonal antibodies targeting glypican-1 and methods of use
|
KR20220008866A
(en)
|
2019-05-14 |
2022-01-21 |
하푼 테라퓨틱스, 인크. |
EpCAM binding proteins and methods of use
|
EP3983542A2
(en)
|
2019-06-17 |
2022-04-20 |
CRISPR Therapeutics AG |
Methods and compositions for improved homology directed repair
|
WO2020257779A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
US20220280656A1
(en)
|
2019-07-31 |
2022-09-08 |
Yale University |
Compositions and methods for treating sickle cell disease
|
CA3149421A1
(en)
|
2019-08-30 |
2021-03-04 |
Yale University |
Compositions and methods for delivery of nucleic acids to cells
|
WO2021081052A1
(en)
|
2019-10-22 |
2021-04-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
High affinity nanobodies targeting b7h3 (cd276) for treating multiple solid tumors
|
CN115768463A
(en)
|
2020-02-21 |
2023-03-07 |
哈普恩治疗公司 |
FLT 3-binding proteins and methods of use
|
JP2023527279A
(en)
|
2020-05-20 |
2023-06-28 |
ロデオ・セラピューティクス・コーポレイション |
Compositions and methods for modulating short-chain dehydrogenase activity
|
MX2023002480A
(en)
|
2020-08-31 |
2023-05-18 |
Univ Yale |
Compositions and methods for delivery of nucleic acids to cells.
|
WO2022093745A1
(en)
|
2020-10-26 |
2022-05-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting sars coronavirus spike protein and uses thereof
|
AU2021400745A1
(en)
|
2020-12-17 |
2023-07-20 |
Vertex Pharmaceuticals Incorporated |
Compositions and methods for editing beta-globin for treatment of hemaglobinopathies
|
US11873485B2
(en)
|
2021-01-26 |
2024-01-16 |
California Institute Of Technology |
Allosteric conditional guide RNAs for cell-selective regulation of CRISPR/Cas
|
EP4319800A1
(en)
|
2021-04-07 |
2024-02-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the treatment of cancer
|
WO2022232612A1
(en)
|
2021-04-29 |
2022-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Lassa virus-specific nanobodies and methods of their use
|
WO2022261018A1
(en)
|
2021-06-07 |
2022-12-15 |
Providence Health & Services - Oregon |
Cxcr5, pd-1, and icos expressing tumor reactive cd4 t cells and their use
|
EP4352226A1
(en)
|
2021-06-07 |
2024-04-17 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
WO2022261017A1
(en)
|
2021-06-09 |
2022-12-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cross species single domain antibodies targeting pd-l1 for treating solid tumors
|
AU2022345251A1
(en)
|
2021-09-17 |
2024-03-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic humanized llama nanobody library and use thereof to identify sars-cov-2 neutralizing antibodies
|
WO2023076881A1
(en)
|
2021-10-26 |
2023-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting the s2 subunit of sars-cov-2 spike protein
|
WO2023086969A2
(en)
|
2021-11-12 |
2023-05-19 |
Ichor Medical Systems Inc. |
Treatment methods
|
WO2024020597A1
(en)
|
2022-07-22 |
2024-01-25 |
The Johns Hopkins University |
Dendrimer-enabled targeted intracellular crispr/cas system delivery and gene editing
|
WO2024050399A1
(en)
|
2022-09-01 |
2024-03-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting hpv e6/e7 oncogenic peptide/mhc complexes
|